In the early conceptualization of MetS, insulin resistance was regarded as its core pathophysiological component, and the syndrome was defined by direct measurements of serum insulin [6] or derived indices such as the Homeostasis Model Assessment of Insulin Resistance (HOMA-IR) [7]. This evidence concerns the gene INS and metabolic syndrome.